3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
19
Breast
4
Lymphoid
2
Tumor-Agnostic
1
Thoracic
1
Sarcoma
1
Other neoplasm
1
Head & Neck
1
Endocrine
1
Conditions
Precancerous Conditions
1
Esophageal Neoplasms
1
Barrett Esophagus
1
Interventions
Cyclophosphamide
13
Peripheral Blood Stem Cell Transplantation
9
Biopsy
9
fludarabine phosphate
8
Busulfan
8
Whole-Body Irradiation
7
Surveys and Questionnaires
6
Mycophenolic Acid
6
Educational Status
6
Early Intervention, Educational
6
Carboplatin
6
fludarabine
5
Tacrolimus
5
Paclitaxel
5
Methotrexate
5
Methods
5
Melphalan
5
Epoetin Alfa
5
Decitabine
5
Cyclosporine
5
Colposcopy
5
Cisplatin
5
Celecoxib
5
Antilymphocyte Serum
5
Aminolevulinic Acid
5
Sulindac
4
Selenium
4
Radiotherapy
4
Patient Reported Outcome Measures
4
Magnetic Resonance Spectroscopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Esomeprazole
×
Other neoplasm
×
Clear all
NCT00357682
2025-05-01
AspECT
University of Oxford
Phase 3
Completed
2,557 enrolled
17 charts